CORDIS
EU research results

CORDIS

English EN

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Project information

Grant agreement ID: 831434

Status

Ongoing project

  • Start date

    1 September 2019

  • End date

    31 August 2026

Funded under:

H2020-EU.3.1.7.

  • Overall budget:

    € 80 803 177,75

  • EU contribution

    € 40 273 191,50

Coordinated by:

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD

Spain

Project description

English EN

Identifying reasons for patients’ negative response to treatment

The identification of the molecular mechanisms that can positively or negatively influence a patient’s response to medical treatment is a key issue among health practitioners. A study promoted by 3TR, a consortium of university institutions, SMEs and leading pharmaceutical companies, will address this issue. This EU-funded project will apply bioinformatics and control methods to collect and analyse data from blood, tissues and other fluids during the entire treatment process. It will create a centralised data platform for better management and implement an inclusive molecular and clinical picture of patients experiencing similar diseases. The project intends to explain the role that our microbiome, genetics and regulatory genomics play during treatment.

Coordinator

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD

Address

Avenida Americo Vespucio 15 Edif S2
41092 Sevilla

Spain

Activity type

Research Organisations

EU Contribution

€ 9 876 529,68

Participants (69)

THE UNIVERSITY OF MANCHESTER

United Kingdom

EU Contribution

€ 682 941,25

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

Germany

EU Contribution

€ 2 700 000

UNIVERSITY OF LEICESTER

United Kingdom

EU Contribution

€ 523 897,95

EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH

Germany

EU Contribution

€ 1 917 499,43

FUNDACIO CENTRE DE REGULACIO GENOMICA

Spain

EU Contribution

€ 1 665 250

EUROPEAN RESPIRATORY SOCIETY

Switzerland

EU Contribution

€ 361 390,08

FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO

Italy

EU Contribution

€ 815 450

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 717 221,25

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands

EU Contribution

€ 120 875

ALACRIS THERANOSTICS GMBH

Germany

EU Contribution

€ 106 250

ATRYS HEALTH, SA

Spain

EU Contribution

€ 237 562,50

AZIENDA OSPEDALE UNIVERSITA PADOVA

Italy

EU Contribution

€ 277 003,50

AZIENDA OSPEDALIERO-UNIVERSITARIA ANNA MEYER

Italy

EU Contribution

€ 146 350

UNIVERSITEIT GENT

Belgium

EU Contribution

€ 141 508

UNIVERSITAIR ZIEKENHUIS GENT

Belgium

REGION HOVEDSTADEN

Denmark

EU Contribution

€ 201 780

CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY

France

EU Contribution

€ 825 030,63

UNIVERSITY OF GLASGOW

United Kingdom

EU Contribution

€ 201 000

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

Germany

EU Contribution

€ 541 266,25

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 287 500

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

Spain

EU Contribution

€ 1 573 843,06

CENTRO DE INVESTIGACION BIOMEDICA EN RED

Spain

EU Contribution

€ 201 512,74

Deutsches Rheuma-Forschungszentrum Berlin

Germany

EU Contribution

€ 229 595

EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING

Belgium

EU Contribution

€ 70 416,25

EUROPEAN LUNG FOUNDATION

United Kingdom

EU Contribution

€ 110 675

GENOS DOO ZA VJESTACENJE I ANALIZU

Croatia

EU Contribution

€ 106 501,56

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 241 798,96

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 125 000

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Portugal

EU Contribution

€ 290 996,25

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 584 499,25

LUPUS EUROPE

United Kingdom

EU Contribution

€ 78 750

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

Germany

EU Contribution

€ 565 627,50

MEDIZINISCHE HOCHSCHULE HANNOVER

Germany

EU Contribution

€ 285 965

OREBRO UNIVERSITY

Sweden

EU Contribution

€ 893 122,25

OWLSTONE MEDICAL LIMITED

United Kingdom

EU Contribution

€ 139 500

PHILIPPS UNIVERSITAET MARBURG

Germany

EU Contribution

€ 201 565

QUEEN MARY UNIVERSITY OF LONDON

United Kingdom

EU Contribution

€ 2 320 291,36

SERVICIO ANDALUZ DE SALUD

Spain

EU Contribution

€ 1 429 125

SERVICIO MADRILENO DE SALUD

Spain

EU Contribution

€ 387 450

SIP SERVICE S.R.L.

Italy

EU Contribution

€ 201 500

SOCIETE DE PNEUMOLOGIE DE LANGUE FRANCAISE

France

EU Contribution

€ 196 425

STICHTING VUMC

Netherlands

EU Contribution

€ 836 688,75

TECHNISCHE UNIVERSITAET DRESDEN

Germany

EU Contribution

€ 192 500

THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

EU Contribution

€ 1 170 877,75

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

EU Contribution

€ 161 201,50

UNIVERSITA DEGLI STUDI DI CATANIA

Italy

EU Contribution

€ 145 302,50

UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO

Italy

EU Contribution

€ 294 944,75

UNIVERSITA DEGLI STUDI DI CAGLIARI

Italy

EU Contribution

€ 294 924,76

UNIVERSITA DEGLI STUDI DI GENOVA

Italy

EU Contribution

€ 236 249,38

UNIVERSITA DI PISA

Italy

EU Contribution

€ 292 500

UNIVERSITAT BASEL

Switzerland

EU Contribution

€ 489 568,75

CLINIQUES UNIVERSITAIRES SAINT-LUC

Belgium

EU Contribution

€ 354 942,75

UNIVERSITE DE BRETAGNE OCCIDENTALE

France

EU Contribution

€ 328 000

UNIVERSITEIT HASSELT

Belgium

EU Contribution

€ 247 825

UNIVERSITETET I BERGEN

Norway

EU Contribution

€ 209 617,50

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

EU Contribution

€ 343 955,31

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 560 011,25

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 890 500

UNIVERSITY OF SOUTHAMPTON

United Kingdom

EU Contribution

€ 201 498,10

UNIVERSYTET MEDYCZNY W LODZI.

Poland

EU Contribution

€ 80 600

VIB

Belgium

EU Contribution

€ 361 018,75

SANOFI-AVENTIS DEUTSCHLAND GMBH

Germany

JANSSEN PHARMACEUTICA NV

Belgium

TAKEDA DEVELOPMENT CENTRE EUROPE LTD

United Kingdom

ASTRAZENECA AB

Sweden

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

United Kingdom

NOVARTIS PHARMA AG

Switzerland

PFIZER LIMITED

United Kingdom

F. HOFFMANN-LA ROCHE AG

Switzerland

Project information

Grant agreement ID: 831434

Status

Ongoing project

  • Start date

    1 September 2019

  • End date

    31 August 2026

Funded under:

H2020-EU.3.1.7.

  • Overall budget:

    € 80 803 177,75

  • EU contribution

    € 40 273 191,50

Coordinated by:

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD

Spain